NP1071326.RAoq ch4np50NKJ-dlCW6S XPdLBlNyw IWJXC4 s-Hfc
has assertion: NP1071326.RAoq ch4np50NKJ-dlCW6S XPdLBlNyw IWJXC4 s-Hfc130 assertion
has provenance: NP1071326.RAoq ch4np50NKJ-dlCW6S XPdLBlNyw IWJXC4 s-Hfc130 provenance
has publication info: NP1071326.RAoq ch4np50NKJ-dlCW6S XPdLBlNyw IWJXC4 s-Hfc130 publicationInfo
type: Nanopublication
created: 2016-05-13T12:49:52+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP1071326.RAoq ch4np50NKJ-dlCW6S XPdLBlNyw IWJXC4 s-Hfc130 assertion
type: Assertion
description: [Furthermore, our results indicate that up to 20% of colorectal cancer may carry mutations in the KRAS codon 61 and BRAF codon 600, which suggests the value of these mutation analyses because patients carrying them are unlikely to respond to cetuximab or panitumumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/23606169
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0